VIR
Vir Biotechnology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.21
+2.51%Leverage
- Debt / equity
- 0.09x
- Net debt / equity
- -0.19x
- Debt / assets
- 0.08x
- Debt / EBITDA
- -0.35x
- Net debt / EBITDA
- 0.69x
Liquidity & coverage
- Current ratio
- 6.04x
- Quick ratio
- 6.04x
- Cash ratio
- 5.57x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $478.8M
Cash & dividend
- FCF / debt
- -2.13x
- Cash flow / debt
- -2.17x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026